Showing results (261-270 of 555) with videos related to
Sort By:
Pageof 56
Swiss Medical Weekly|December 5, 2019
Position statement on the use of biosimilars in inflammatory bowel diseaseEmanuel Burri, Pascal Juillerat, Michel H Maillard, et al.Journal of Crohn'S & Colitis|April 16, 2014
Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBDGiovanni Latella, Gerhard Rogler, Giorgos Bamias, et al.Journal of Crohn'S & Colitis|October 13, 2014
Cellular and Molecular Mediators of Intestinal FibrosisIan C Lawrance, Gerhard Rogler, Giorgos Bamias, et al.Biochemical and Biophysical Research Communications|September 15, 2024
Size of lipid emulsion droplets influences metabolism in human CD4+ T cellsNazek Noureddine, Gregory Holtzhauer, Paulina Wawrzyniak, et al.Digestion|February 16, 2005
Drug safety in the treatment of Crohn's diseasePascal Juillerat, Christian Felley, Christian Mottet, et al.Digestion|February 16, 2005
Severe and steroid-resistant Crohn's diseasePierre Michetti, Christian Mottet, Pascal Juillerat, et al.Digestion|February 16, 2005
Obstructive fibrostenotic Crohn's diseaseFlorian Froehlich, Pascal Juillerat, Christian Mottet, et al.Digestion|February 16, 2005
Treatment of gastroduodenal Crohn's diseaseChristian Mottet, Pascal Juillerat, Jean-Jacques Gonvers, et al.Digestion|February 2, 2008
Drug safety in Crohn's disease therapyPascal Juillerat, Valérie Pittet, Christian Felley, et al.BMC Microbiology|February 28, 2024
Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in miceJacqueline Wyss, Tina Raselli, Annika Wyss, et al.Pageof 56